Imunon CMO granted 4,211 shares as salary

Imunon’s chief medical officer received 4,211 shares as stock compensation in place of part of his cash salary, increasing his direct holdings to 41,288 shares.

Rhea-AI Filing Summary

Imunon, Inc. (symbol: IMNN) is the issuer of record for a Form 4 filing submitted to the SEC. Faller Douglas Vincent reported acquisition or exercise transactions in this Form 4 filing.

Imunon, Inc. (IMNN) reported that Chief Medical Officer Douglas Vincent Faller received an equity award on September 11, 2026. He was granted 4,211 shares of Common Stock at a value of $1.47 per share, issued in lieu of cash for a portion of his base salary, bringing his directly held stake to 41,288 shares. No transactions were reported under a Rule 10b5-1 trading plan.

Insider Trade Summary

Grant/Award: 4,211 shares

Grant/Award 1 txn

Insider Faller Douglas Vincent

Role Chief Medical Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1	4,211	$1.47	$6K

Holdings After Transaction: Common Stock — 41,288 shares (Direct)

Footnotes (1)

1. F1. Stock granted in lieu of cash for portion of base salary

Key Figures

Shares granted: 4,211 shares Grant valuation price: $1.47 per share Post-transaction holdings: 41,288 shares +1 more

4 metrics

Shares granted 4,211 shares Common Stock grant on September 11, 2026

Grant valuation price $1.47 per share Value used for the September 11, 2026 stock grant

Post-transaction holdings 41,288 shares Directly held Common Stock after the grant

Number of acquire transactions 1 transaction Non-derivative grant, award, or other acquisition reported

Key Terms

Grant, award, or other acquisition, in lieu of cash, Rule 10b5-1

3 terms

Grant, award, or other acquisition financial

"classified as a grant, award, or other acquisition of Common Stock"

in lieu of cash financial

"Stock granted in lieu of cash for portion of base salary"

Rule 10b5-1 regulatory

"No transactions were reported under a Rule 10b5-1 trading plan"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Imunon (IMNN) disclose for Douglas Vincent Faller?

Imunon disclosed that Chief Medical Officer Douglas Vincent Faller received a grant of 4,211 shares of Common Stock on September 11, 2026 as compensation, classified as a grant, award, or other acquisition rather than an open-market purchase.

At what price were the IMNN shares granted to the chief medical officer?

The 4,211 shares of Imunon Common Stock granted to the chief medical officer were valued at $1.47 per share. This price is used to value the equity award reported for September 11, 2026.

How many IMNN shares does the chief medical officer hold after this Form 4 transaction?

After the September 11, 2026 equity grant, Chief Medical Officer Douglas Vincent Faller directly holds 41,288 shares of Imunon Common Stock, according to the reported post-transaction holdings figure.

Was the Imunon (IMNN) Form 4 transaction made under a Rule 10b5-1 trading plan?

No. The Form 4 indicates that the Rule 10b5-1 checkbox is not affirmed, and there is no footnote stating that the September 11, 2026 equity grant was made pursuant to a Rule 10b5-1 trading plan.

What is the nature of the IMNN stock granted to the chief medical officer?

The 4,211 IMNN shares were stock granted in lieu of cash for a portion of base salary, meaning part of the chief medical officer’s cash compensation was paid in the form of Common Stock instead of cash.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/15/2026 - 12:42 PM Accepted by SEC EDGAR 09/15/2026 - 12:41 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Faller Douglas Vincent

(Last) (First) (Middle)

C/O IMUNON, INC.

997 LENOX DRIVE, SUITE 100

(Street)

LAWRENCEVILLE NEW JERSEY 08648

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Imunon, Inc. [ IMNN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Medical Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/11/2026		A		4,211(1)	A	$1.47	41,288	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Stock granted in lieu of cash for portion of base salary

	/s/ Jeffrey W Church, Attorney in Fact for Douglas Faller	09/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)